Neeraj Agarwal, MD, FASCO (@neerajaiims) 's Twitter Profile
Neeraj Agarwal, MD, FASCO

@neerajaiims

Medical Oncologist. Editor-in-chief: @ASCO Daily News; Presidential Endowed Chair, @HuntsmanCancer (NCI-CCC) @UUtah, FCOI bit.ly/3A3u2KL

ID: 4761682514

linkhttps://bit.ly/3JApRJd calendar_today15-01-2016 06:32:10

13,13K Tweet

15,15K Takipçi

770 Takip Edilen

Neeraj Agarwal, MD, FASCO (@neerajaiims) 's Twitter Profile Photo
Neeraj Agarwal, MD, FASCO
@neerajaiims

a year ago

Breaking news (practice changing) from ESMO - Eur. Oncology #ESMO24 👉Tom Powles presents the 1st results of the ph3 Niagara trial of cisplatin + gemcitabine +|- durvalumab in MIBC #bladdercancer 👉Significant improvement in DFS (HR 0.68) & OS (HR 0.75) with durvalumab OncoAlert UroToday.com

Breaking news (practice changing) from <a href="/myESMO/">ESMO - Eur. Oncology</a> #ESMO24 👉<a href="/tompowles1/">Tom Powles</a> presents the 1st results of the ph3 Niagara trial of cisplatin + gemcitabine +|- durvalumab in MIBC #bladdercancer 👉Significant improvement in DFS (HR 0.68) &amp; OS (HR 0.75) with durvalumab <a href="/OncoAlert/">OncoAlert</a> <a href="/urotoday/">UroToday.com</a>